Tom Salmon

Board Director

Director

OLD National BancorpBerry Global Group, Inc.Magnera Corp

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 1 buy · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€181k

▼ Sales (0 ops.)

—

Latest filing published 06 Nov 2025 for Magnera Corp, €70k. Read the official filing

Filing timeline

BuySale

Tom Salmon

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Tom Salmon: trading record in brief

Tom Salmon (board member) discloses dealings in 3 companies, chiefly Old National Bancorp /IN/, Magnera Corp and Berry Global Group, Inc. The record holds 7 filings, for trades running from 31 March 2021 to 4 November 2025.

The open-market record is one-sided, with 1 purchase worth €181k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises. Since January 2025: 1 purchase and no sales on the market.

The latest filing, published on 6 November 2025, reports an option exercise of €70k in Magnera Corp. The last purchase on record was published on 30 May 2025, which is 506 days ago. Filings reach the SEC (Form 4) feed a median of 19 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.